Dive into our report and…
- Learn how the cell therapy funding landscape has grown over the years, with a focus on deals and investments made in 2021 and 2022.
- Discover some of the key players involved in the cell therapy space and the products available on the market.
- Learn about how treatments are categorized and which medical fields are harnessing this technology.
- Discover the future of cell therapy and which new indications are being targeted by researchers.
More about this report:
By 2028, the value of the global cell therapy market is projected to surpass $45B, up from less than $20B in 2020. Some industry insiders even anticipate that cell and gene therapies will overtake conventional drug therapies in the not-so-distant future, with sales projected to significantly increase by 2026.
This report gives an overview of the global cell therapy industry in 2022, highlighting several players in the space; key licensing deals and investments; and the effect of the Covid-19 pandemic on the industry. It also takes a closer look at what cell therapy entails, from delineating the different subtypes to the different medical fields employing cell therapies. A particular focus is placed on adoptive cell therapies, including CAR-T cell therapy, which have seen a major influx in interest in the previous years.
